• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.68 Up 0.03(1.82%) Mar 27, 4:06PM EDT
    |After Hours : 1.68 0.00 (0.00%) Mar 27, 4:26PM EDT
    Add to Portfolio
    Prev Close:1.65
    Open:1.64
    Bid:1.60 x 100
    Ask:1.68 x 400
    1y Target Est:4.56
    Beta:1.12
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:1.63 - 1.70
    52wk Range:0.97 - 2.02
    Volume:298,223
    Avg Vol (3m):645,858
    Market Cap:251.50M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBUp 1.82%251.50M
    LLYUp 0.19%78.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):39.36
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.13
    Quarterly EPS Est (Mar-15) :-0.03
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback